Robert S. Langer Net Worth

Robert S. Langer has an estimated net worth of $2.8 billion, according to Forbes Real-Time Billionaires, Robert S. Langer profile (figures as of October 20, 2026). That is up from $1.6 billion in 2021.

Robert S. Langer is a scientist, inventor, and professor at the Massachusetts Institute of Technology. He leads the Langer Lab and is one of the 12 Institute Professors at MIT. His research work is known across biotechnology, especially in drug delivery systems and tissue engineering. He has published more than 1,500 articles, holds more than 1,400 patents and patent applications, and has had that work licensed more than 400 times by biotech and pharma companies.

His wealth comes from biotech, not entertainment or sports. Langer was a founder of Moderna and still owns a 3% stake in the company, according to Forbes, and he has never sold a share. He also held stakes in SQZ Biotechnologies, Seer, and Sigilon Therapeutics, which were founded by him and postdoc students from his lab. Forbes currently values his fortune at $2.8 billion on October 20, 2026.

How Robert S. Langer built his wealth

Langer made his name through science and engineering, then turned that work into business value through patents, licensing, and company building. Forbes places him in healthcare and calls him self-made. At MIT, he has led a major research lab while producing inventions used in biotech and pharma. His patent portfolio is unusually large, with more than 1,400 patents and patent applications, and those rights have been licensed more than 400 times.

A big part of his fortune is tied to companies that grew out of his lab and research network. Forbes says he was a founder of Moderna, the Cambridge biotech company, and that he owns a 3% stake and has never sold a share. Forbes also notes that he held stakes in SQZ Biotechnologies, Seer, and Sigilon Therapeutics, which were founded by him and postdoc students from his lab. That mix of equity stakes and inventions explains much of his wealth.

Forbes net worth timeline

Forbes estimated Langer's net worth at $1.6 billion in 2021, and kept the same figure in 2022 and 2023. In 2024, that estimate moved down to $1.2 billion on the World's Billionaires list. Those estimates sit alongside a career built on biotech holdings, especially his Moderna stake, plus interests in other companies linked to his lab. Forbes also notes that he never sold a Moderna share.

By October 2026, Forbes' real-time billionaires tracker put him at $2.8 billion. That is a much higher figure than the last annual list estimate in 2024. The available details point back to the same main ingredients: his 3% position in Moderna, his other biotech stakes, and a long career of patents and licensing. His money story is closely tied to science translated into companies, ownership, and intellectual property.